Windtree Therapeutics, a Nasdaq-listed company, has announced plans to buy $60 million BNB as part of its push for a cryptocurrency treasury strategy.
Windtree Therapeutics, a Nasdaq-listed company, has announced plans to buy $60 million BNB as part of its push for a cryptocurrency treasury strategy.